SEEL Historical Earnings image   This SEEL historical earnings page last updated 11/23/2022
SEEL Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/10/2022NA
Q2 20228/5/2022NA
Q1 20225/10/2022NA
Q4 20213/4/2022NA
Q3 202111/5/2021NA
Q2 20218/6/2021NA
Q1 20214/30/2021NA
Q4 20203/11/2021NA
Q3 202011/12/2020NA
Q2 20208/14/2020NA
Q1 20205/7/2020NA
Q4 20193/17/2020NA
Q3 201911/7/20190.00B
Q2 20198/1/2019NA
Q1 20195/21/2019NA
Q4 20183/28/2019NA
Q3 201810/31/2018NA
Q2 20188/9/2018NA
Q1 20185/3/2018NA
Q4 20173/1/2018NA
Q3 201711/2/2017NA
Q2 20178/2/2017NA
Q1 20175/11/2017NA
Q4 20163/13/20170.00B
Q3 201611/8/20160.00B
Q2 20168/4/20160.00B
Q1 20165/9/20160.00B
Q4 20153/9/20160.00B
Q3 201511/5/20150.00B
Q2 20158/5/20150.00B
Q1 20155/11/20150.00B
Q4 20143/16/20150.00B
Q3 201411/10/20140.00B
Q2 20148/12/20140.01B
Q1 20145/12/2014NA
Q4 20133/17/20140.00B
Q3 201311/12/20130.03M
Q2 20138/14/20130.00B
Q1 20135/10/20130.00B
Q4 20123/18/20130.00B
SEEL Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/10/2022-0.180
Q2 20228/5/2022-0.200
Q1 20225/10/2022-0.130
Q4 20213/4/2022-0.280
Q3 202111/5/2021-0.110
Q2 20218/6/2021-0.080
Q1 20214/30/2021-0.280
Q4 20203/11/2021-0.130
Q3 202011/12/2020-0.090
Q2 20208/14/2020-0.080
Q1 20205/7/2020-0.140
Q4 20193/17/2020-0.270
Q3 201911/7/2019-0.130
Q2 20198/1/2019-0.090
Q1 20195/21/2019-3.980
Q4 20183/28/2019-0.050
Q3 201810/31/2018-0.12
Q2 20188/9/2018-0.1
Q1 20185/3/2018-0.14
Q4 20173/1/2018-0.16
Q3 201711/2/2017-0.29
Q2 20178/2/2017-0.15
Q1 20175/11/20171.04
Q4 20163/13/2017-0.36
Q3 201611/8/2016-0.19
Q2 20168/4/2016-0.05
Q1 20165/9/2016-0.09
Q4 20153/9/2016-0.05
Q3 201511/5/2015-0.1
Q2 20158/5/2015-0.1
Q1 20155/11/2015-0.13
Q4 20143/16/2015-0.09
Q3 201411/10/2014-0.08
Q2 20148/12/20140.05
Q1 20145/12/2014-0.09
Q4 20133/17/2014-0.04
Q3 201311/12/2013-0.09
Q2 20138/14/2013-0.12
Q1 20135/10/2013-0.23
Q4 20123/18/2013-0.53
Quotes delayed 20 minutes

Email EnvelopeFree SEEL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Seelos Therapeutics (SEEL) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SEER Historical Earnings
SELB Historical Earnings
SEM Historical Earnings
SERA Historical Earnings
SESN Historical Earnings
SGEN Historical Earnings
SGFY Historical Earnings
SGHT Historical Earnings
SGMO Historical Earnings
SGRY Historical Earnings
What was the record high SEEL historical earnings result?
In terms of earnings or revenue, what is the best SEEL historical earnings result that Seelos Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest SEEL historical earnings result was set in Q1 2017, when Seelos Therapeutics posted results of 1.04/share. The most successful revenue quarter within our data set was Q2 2014 when Seelos Therapeutics reported revenue of 0.01B.

What was the lowest Seelos Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest SEEL has reported, and when?

✔️Accepted answer: Within our data set, the lowest SEEL historical earnings result was set in Q1 2019, when Seelos Therapeutics posted results of -3.980/share. The smallest revenue quarter within our data set was Q3 2022 when Seelos Therapeutics reported revenue of NA.

On this page we presented the SEEL historical earnings date information for Seelos Therapeutics. Reviewing that SEEL Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2017, when SEEL posted gaap of 1.04/share. Meanwhile the lowest SEEL historical earnings result was in Q1 2019, when SEEL posted gaap of -3.980/share. Moving to Seelos Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2014 when SEEL reported 0.01B in revenue, while the smallest revenue quarter was Q3 2022 when SEEL reported NA in revenue.

For self directed investors doing their due diligence on SEEL or any other given stock, their research can benefit from looking into all of the Seelos Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Seelos Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for SEEL. Thanks for visiting, and the next time you need to research SEEL historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: SILK Insider Buying, GKC Videos, Funds Holding CLBS.

 

SEEL Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.